CytoDyn Inc (QB) (CYDY) News

"As noted in our prior release, we recently completed the kickoff meeting with Syneos Health, the CRO for the study, and enrollment efforts are set to begin in January."

Dec 2024 Letter to Shareholders.

Do you need the link or can you use Google all by yourself?

You longs are absolutely clueless no wonder you are so deep in the red

Your name is certainly fitting I'll give you that

Why don't you post that 'January' quote? Go ahead.....we'll wait.

They also said they would start recruiting in January. You taking their word as gospel is not savvy my friend.

I dunno but over a month ago this is what they said:

The CytoDyn/Syneos study teams have now approved eight clinical sites and counting to participate in CytoDyn’s Phase II study of patients with CRC and refractory disease. These clinical sites will include a mix of both large community practices as well as academic centers which all have well-established track records of superior work and high enrollment. With our clinical trial agreements in place and study initiation visits about to start, we expect screening of patients into the CRC study to commence shortly.

As previously mentioned, Dr. Ben Weinberg from Georgetown University and the MedStar Health Alliance will be the lead Principal Investigator for the CRC study. Per the FDA’s request, the first five patients enrolled will receive 350 mg of leronlimab SQ once/week in combination with TAS-102 and bevacizumab. After a preliminary safety review by the Data and Safety Monitoring Board (“DSMB”), subsequent patients will be randomized to 350 or 700 mg of weekly leronlimab along with the same background regimen. The DSMB will perform a second safety review after the first 20 patients have completed at least 1 cycle of therapy and can then recommend restricting further enrollment to a single dose level, if deemed appropriate.


I'd say there is a good chance we'll see the trial site updated soon.

https://www.cytodyn.com/pipeline

Poised for a big leap forward. Many investors looking at this for the first time then find the upside potential highly likely.
Anyone of these indications could be the catalyst at any moment. Worth a starter? Worth the Risk v. Reward?
Worth adding following the six month uptrend? AS pharmaceuticals go, this one has the most potential in the shortest time
for more gains. We may well be on the brink of an amazing uptrend with European Conference coming up in a few weeks
and perhaps some other announcements on the studies or with partnership in one of the many indications.

Great weekend for all!! $CYDY$ 2025

Any UPDATE on ANY real clinical trial with Leronlimab??

Is build good things about a few pennies in share price or actually trying to get approval from FDA??

Still shows est start of FEB 2025
Still shows est completion of JUN 2028
Still shows NOT YET RECRUITING

It's Friday baby and I need some ticks down to grab. Get with it pigeons. The scrabbles you leave are not worth dialing in for.
Give me my Cheapies. Hurry. Just do it and quit squabbling. Geez, don't get no respect around here. No respect at all.

Stroke research: UCLA scientists studying AIDS drug to accelerate stroke recovery

A new collaborator, Dr. Tom Carmichael, Professor and Chair of Neurology at the University of California, Los Angeles, has published important preclinical observations demonstrating how a small molecule CCR5 inhibitor can expedite recovery following a cerebrovascular accident (“CVA” or “stroke”). CytoDyn is working with Dr. Carmichael and Dr. Kate Schunke at the University of Hawaii to conduct a preclinical study of stroke in transgenic mice that express human CCR5. We are excited by this initiative, given our view that there is an unmet need for innovative and effective treatment paths for patients in this category, and our belief that the market for therapies to treat stroke and/or traumatic brain injury could grow significantly over the next several decades. Dr. Carmichael will also be advising on the pilot study of AD to be initiated at Cornell Medical Center in New York.

LERONLIMAB SUMMARY 4/24/2025


BUILDGOODTHINGS

Leronlimab info: click here
Some resources for understanding Leronlimab
(updated 4/24/2025)

science:
https://www.cytodyn.com/our-science

FAQ for investors and patients:
https://www.cytodyn.com/investors/investor-faqs

pipeline: The drug leronlimab across multiple diseases
https://www.cytodyn.com/pipeline

recent news:

February 2025 Metastatic Triple Negative Breast Cancer patient survival observations https://www.cytodyn.com/investors/news-events/press-releases/detail/635/cytodyn-announces-promising-survival-observations-in-mtnbc

March 2025 Letter to shareholders https://www.cytodyn.com/investors/news-events/press-releases/detail/636/march-2025-letter-to-shareholders

papers, posters, abstracts
https://www.reddit.com/r/Livimmune/comments/1jwy04w/some_of_the_papers_posters_and_abstracts/

Too busy « averaging down » aka leveraging up aka holding the bag!

Cydy longs went from giddy to fuming today and still no recruitments

Come now pidgeons. Don't fail me now. Tengo hambre.
Feed me some cheapies again.

But, you claimed you've been adding at these prices, so you aren't up on all those shares as you claim. In fact, you never mentioned to anyone you were buying when the stock was at 12 cents. Why is that? Why mention it now?
The stock is up against resistance now, I'm willing to bet where this stock will be headed after the pump and dumpers do their thing once again.

Exactly. Guess he forgot to check in with us to ask us, my dividends, we’ll, they be good

You must be looking in the mirror. Rear view mirror.

Up over 41% in worst account!! Got 4 of em.
Up 127.4% off the low a few months back.

Yep, don't like my worst account at all. Guess I will have to keep adding before this baby runs hard.

How sad to have green bags busting out. Going to need some Super Sacks.
https://www.toplinebags.com/resources/understanding-un-certified-super-sacks

EXACTLY. Well said. All these gamblers care about is the stock price, they get giddy when it goes up and angry when it goes down. Literally nothing ever about the lack of progress for the company. Have they recruited anyone yet???????? April is almost over. But nope, the stock is up 2 pennies so all is well in cydy land!!

Worst group of investors on the planet

Shouldn't the point be getting trials run ?? Trying for FDA approval of Leronlimab??

Is this just to watch stock go up pennies and declare success??
Just to make up stories about partners and NDA and Bill Gates ??
More concern with nodder defense and success than any advancement of clinical trials??
More fake success in some mouse study or monkey butts??

Redesign website every few months?? Talk about random presentations once or twice a year??
Crow and gloat about Dr Pestell and firing him for "cause"--then blow trumpets about his credibility and rock star presentation standing by some poster??

What about submitting for TNBC BTD?? If that data is there--wait another year or 2?? Still don't know the correct SOC to use for submission??

Good question--what is the point if it is NOT FDA approval??
Seems to be enriching the private investors HUH??

The stock was $10 once upon a time... Its up 69% from where it was 6 months ago. What is your point?

You keep making me waste my one post per day on you.
Go look to the right of every post and see what the high was! Sheesh!
When a stock goes from .4945 (2/24/25) to .23...what percentage is that??

C'mon now, figure these things out yourself.

BS, you weren't even around when the pps hit 7.
How do you like the company turnaround. Did you notice?

Yes we are watching the same trash get pumped and dumped the only difference is I'm not dumb enough to throw chips in this garbage I shorted from $7 to $1 and I'm perfectly happy with that. No see what I'm more interested in is what they are actually doing, what progress they are making, not what posters they are presenting. Why? Cause I love watching bad companies fail

As an investor, if you are one, you too should be more concerned with what they are doing not what pump and dumps are happening. Therefore, I ask again, recruited anyone yet?

Notice how only shorts chirp in daily about the few tiks up or down. Boring.

It takes reading skills just to get through your post, someone ask you, where you got it was down 50% loss the past two months, so again, where did you see it from your post on the 11th, it’s just a question, not an attack

Not sure if you are lacking in reading skills or math skills?
A week ago I posted that a couple of months ago it was double what it was the day I posted. Yesterday it had come up some, so only down 30% from a couple of months ago....today it is down again, do I need to refigure the math for you?
I notice every single post you make is an attack on someone.

djjazzjeff- I believe your watching the same up n downs, same ticker symbol as long and shorts here. Btw- CYDY is holding itself within the market.
Chump

Who cares if it goes up because idiot longs never sell on a pump they just watch it go up and come back down. They start recruiting yet?????

So you just posted it was down 50% over a week ago, now down to 30% over two months, where do you get your info, let’s see it

You mean because the stock bounced back to the resistance line? Bully for you!
Resistance currently at .229. Let's see it finish the week above there first before getting too excited about you only being down about 30% from 2 months ago.

Interesting, especially when the Dow is off over a thousand points, to be up 12% + and not a peep out of the usual pumpers and pissers???

did not want to offer coverage of certain preventive services, including PrEP medications for HIV. How does this play out for HIV meds?? Why wasn't the BLA ever filed?? Why wasn't the BTD for TNBC ever redone with the correct SOC?? Just to wait years and years for a poster?? Stop the nonsense--run the trial

The lawsuit was filed at the end of the first Trump administration by a Texas business and other individuals who did not want to offer coverage of certain preventive services, including PrEP medications for HIV, because of their religious and moral objections to those treatments.

What a twist--the T rump admin defending Obamacare (ever notice the "repeal Obamacare" nonsense has disappeared??)

https://www.cnn.com/2025/04/20/politics/obamacare-affordable-care-act-supreme-court-rfk-jr/index.html

Save the monkeys
https://thehill.com/homenews/5256937-research-monkeys-entangled-in-trump-harvard-dispute-get-reprieve/

From Reddit r/Livimmune
•
23 hr. ago
BuildGoodThings
Grit

Yes that’s what most CytoDyn (CYDY) investors display! We’ve been though far more than most investors. The details are a very long story, so let’s cut to the chase.

The “why are we here” is what I want to discuss. For me it starts with the data of how people with serious conditions got better and had fewer serious side effects. First it was in HIV, then the severe Covid patients in ICU, and now it’s the Breast Cancer patient data that is about to hit the international fan. This stuff is IMO incredible and it’s going to become better known.

Right up there with the science, is that we all know people who have suffered with diseases that CytoDyn may be able to treat, and we yearn for our friends, family and ourselves to have better options.

Lastly, if the science data stays on track, the number of people who may want the drug, will explode to enormous numbers which translates to potentially indescribable profits.

I’m here for all three reasons, but to be honest, I also want some serious recognition after what happened to the company and its investors from 2020-2023.

My tale in that period is that Covid basically killed off 2 of my 3 main investments, bankrupted my employer, and forced me to more or less watch a parent die through a window.

Countless others have stories that are far worse which leave me speechless.

The purpose of this note? To tell you that I’m proud to know people with grit and I see a lot of that here!

aye Mate twas a great day for trading thanks to all pigeons.... green is so good. Up strong for the year!
Looking forward to Christmas in June.

Yea, you have a good wknd also, green till Monday, thanks for playing

I personally feel after the conference in mid-May within 30 days after that we will have at least in my opinion three big pharma companies knocking at our door. After all we do have something to offer for mankind, women kind, children kind, and who knows what else at this point. Of course it would be animals. Thank you all you longs for hanging in there You will be well rewarded IMO. YOU KILL JOY BASHERS NEED TO TAKE A LONG WALK OFF OF A SHORT PAIR WHEN THE OCEAN IS REALLY CHURNING UP. OR GO PLAY IN THE FREEWAY TRAFFIC. THERE'S A COUPLE OF YOU THAT I WISH YOU'D DO THAT RIGHT AWAY. AND YOU KNOW WHO YOU ARE!!

A “DIP” ONLY FOR BAGHOLDERS LOL

NICE FALL BEFORE THE WEEK-END

Love it. Thanks to pigeons I play these dips. Love my green bags that keep getting larger.

Looking forward to that huge European Cancer Conference. The notoriety is going to be superb.

Semana Santa is here... Good Friday long weekend.

Maybe I will get another good fill today.

$CYDY$
CytoDyn Stock Price Performance

5 Day
Performance
-4.29%
1 Month
Performance
-15.37%
3 Month
Performance
+33.29%
6 Month
Performance
+39.87%
Year-To-Date
Performance
+83.23%
1 Year
Performance
+35.81%

Anything to deflect from the new dilution. Dr J needs to explain 100% why shares are not sold ATM
The shares with free warrants--the Fife nonsense--Why is this the funding??. Get full mkt value. To heck w Tonya and her protection of private investors. Enough bleed

Start the R C T. Stop standing around pretending mice and monkeys will get partners. Stop hiring firing hiring Dr Pestell yo yo--and pretending standing by some poster is the greatest thing ever. We heard the same thing about NASH. Covid. Brazil. Phillipines. We hear Bill Gates is evil--then Bill Gates is savior. We hear amawrecks do fantastic job. We hear minimal dilution. We hear insiders can never buy shares on open mkt. We hear 13D evil. S T F U

Start the R C T--ends in 2028. Was sched to start FEB 2025.

Dude the stock is barely trading at all. There's a billion shares and look at this volume. It's 50% down from its recent pump. It's over.

Gotta like this trading range holding , indicative of some news surfacing. In a hold pattern.
Chump

Macro environment is looking UP! https://www.zerohedge.com/news/2025-04-03/can-moderna-or-rest-vaccine-makers-survive-rfks-vaccine-crackdown-during-global

Is this "link" about the NASH/MASH partnership you post about??
No one will find that link

Its possible that person does not know/understand --For the avoidance of doubt, Chicago Venture Partners (“CVP”) currently holds two notes with Borrower
– one in the name of Uptown Capital, LLC and another in the name of Streeterville Capital, LLC – and the
Monthly Payment Amount will accrue and be applicable to one of the two notes on a monthly basis. CVP may,
at its discretion, choose which of the two notes it would like to apply the Monthly Payment Amount to on a
month-by-month basis..

BUT you would "think" they could grasp --on some level--
LENDER: Streeterville Capital, LLC
By: /s/ John M. Fife
John M. Fife, President
BORROWER: CytoDyn, Inc.
By: /s/ Mitch Cohen
Name: Mitch Cohen
Title: Interim CFO

LENDER: Uptown Capital, LLC
By: /s/ John M. Fife
John M. Fife, President
BORROWER: CytoDyn, Inc.
By: /s/ Mitch Cohen
Name: Mitch Cohen
Title: Interim CFO




But NEVER let FACT get in the way of opinion

Yea, those lawsuits are scary stuff I tell ya

And the latest 10Q filing by the company proves again that I was correct, and that you were wrong - Fife is bleeding dry this dead horse:

Extension(s) to April 2, 2021 and April 23, 2021 Notes
In April 2025, the Company and the holders of convertible notes issued by the Company on April 2, 2021 and April 23, 2021 (the
“Noteholders”) agreed to extend the maturity date of each of the notes by one year (the ”Extension Period”). The Company agreed to a total
monthly payment of $750,000 covering both notes until the extended maturity date. During the Extension Period, the Company will issue
shares of common stock equal in value to the $750,000 monthly payment calculated based on the lower of (i) the previous trading day’s
closing price, or (ii) the average of the five previous trading day closing prices. The interest rate for each note was also lowered to 6% as
part of the extension.
https://www.cytodyn.com/investors/sec-filings/all-sec-filings/content/0001558370-25-004774/0001558370-25-004774.pdf

On January 29, 2024, two purported stockholders filed a purported derivative lawsuit against certain of the Company’s former officers,
certain current and former directors, and the Company as a nominal defendant, in the Delaware Court of Chancery. The complaint generally
makes allegations similar to those set forth in the Consolidated Derivative Suit and asserts that the individual defendants breached their
fiduciary duties by allowing the Company to make false and misleading statements and by failing to maintain an adequate system of
oversight and controls. The complaint also asserts claims against certain individual defendants for breach of fiduciary duty arising from
alleged insider trading.

A side note for current shareholders. Always fun to remember these lawsuits are still pending.

Wow scary stuff lol

Yawn 🥱

"strategic partnerships" for inflammation.

HIV faint for a reason.

CMC ironclad for ***. Some of the money went to CRC. The rest went to THE…

.4 mill for CRC rough math and then the other .557 mill was used for ⚡️

.735 mill on partner R&D. 40 percent jump……

EhhHhehehehe cydy must pay $750,000 a month in stock for the next year, guaranteeing ongoing dilution. Great investment longs!!!!